For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
Adult attention deficit hyperactivity disorder and autism spectrum disorder
Adult attention deficit hyperactivity disorder and autism spectrum disorder

Adult attention deficit hyperactivity disorder and adult autism spectrum disorder are fairly new and exciting areas of research in psychiatry. In this article, Sidhesh Phaldessai examines our increasing understanding of the symptom presentation and management of these neurodevelopmental disorders in adults, which is forcing a significant revision of how we understand and treat a range of psychological symptoms in adults, including secondary anxiety, mood and personality disorder
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.
1. Volkow ND, Swanson JM. Clinical practice: Adult attention deficit-hyperactivity disorder. N Engl J Med 2013;369(20):1935–44.
2. Fayyad J, De Graaf R, Kessler R, et al. Cross-national prevalence and correlates of adult attention-deficit hyperactivity disorder. Br J Psychiatry 2007;190:402–09.
3. Biederman J, Faraone SV. The effects of attention-deficit/hyperactivity disorder on employment and household income. MedGenMed 2006;8(3):12.
4. Ronald A, Simonoff E, Kuntsi J, et al. Evidence for overlapping genetic influences on autistic and ADHD behaviours in a community twin sample. J Child Psychol Psychiatry 2008;49(5):535–42.
5. Ouyang L, Fang X, Mercy J, et al. Attention-deficit/hyperactivity disorder symptoms and child maltreatment: a population-based study. J Pediatr 2008;153(6):851–56.
6. National Institute for Health and Care Excellence. Attention deficit hyperactivity disorder: diagnosis and management. NICE guideline NG87, 13 September 2019.
7. Lai MC, Kassee C, Besney R, et al. Prevalence of co-occurring mental health diagnoses in the autism population: a systematic review and meta-analysis. Lancet Psychiatry 2019;6(10):819–29.
8. Doherty M, McCowan S, Shaw SC. Autistic SPACE: a novel framework for meeting the needs of autistic people in healthcare settings. Br J Hosp Med (Lond) 2023;84(4):1–9.